3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
Specimen Handling
98
Biopsy
69
Magnetic Resonance Spectroscopy
63
pembrolizumab
46
Cyclophosphamide
43
fludarabine
38
Carboplatin
22
venetoclax
19
Nivolumab
18
Cetuximab
18
Bevacizumab
17
Radiotherapy
16
fludarabine phosphate
15
Cisplatin
15
X-Rays
14
Ipilimumab
13
Fluorouracil
13
Cytarabine
13
Temozolomide
12
Leucovorin
12
Irinotecan
12
atezolizumab
11
Radiation
11
Paclitaxel
11
Azacitidine
11
durvalumab
10
Oxaliplatin
10
Injections
10
Gemcitabine
10
Dexamethasone
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Curcumin
×
30 days
×
Clear all
NCT06626230
2026-05-18
Safety of Anal Curcumin
Emory University
Phase 1
Recruiting
48 enrolled